We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand how chemotherapy affects your immune system and your risk of COVID-19. Learn about management, prevention, and when to seek medical advice.
Chemotherapy, a cornerstone treatment for many cancers, plays a vital role in fighting the disease. However, it's well-known that chemotherapy can significantly impact the body's immune system. This raises an important question for patients undergoing treatment: Does chemotherapy increase the risk of contracting COVID-19? This article aims to provide a clear and practical understanding of this complex issue, tailored for our readers in India.
Chemotherapy works by targeting rapidly dividing cells, a characteristic of cancer cells. Unfortunately, this aggressive approach doesn't always distinguish between cancerous and healthy cells. Cells that divide quickly, such as those in the bone marrow responsible for producing infection-fighting white blood cells (specifically neutrophils), can also be affected. When these cells are compromised, the body's ability to fight off infections, including viruses like SARS-CoV-2 (the virus that causes COVID-19), is weakened. This state of having a low white blood cell count is known as neutropenia, and it typically occurs 7-12 days after each chemotherapy dose, potentially lasting for about a week. During this period, the risk of infection is heightened.
The concern about increased COVID-19 risk during chemotherapy is valid. Early studies, including one from 2020, indicated that while chemotherapy itself might not be directly linked to severe COVID-19 outcomes, having a low white blood cell or neutrophil count at the time of diagnosis was associated with less favorable results. However, subsequent research has provided more nuanced insights. Several studies have found that receiving chemotherapy in the weeks leading up to a COVID-19 diagnosis did not necessarily correlate with a higher risk of death from the virus. The impact of chemotherapy on the immune system is not uniform and depends on several factors:
If you are undergoing chemotherapy and contract COVID-19, your medical team will make decisions based on your specific situation. It's important to know that there is currently no evidence suggesting that contracting COVID-19 will negatively impact the effectiveness of your cancer treatment. However, your chemotherapy schedule might be adjusted. Treatment could be delayed until your COVID-19 symptoms resolve or you test negative. Your doctor may also consider medications to help prevent severe illness from COVID-19. These can include antiviral treatments like nirmatrelvir with ritonavir (Paxlovid), which can be prescribed to reduce the severity of the infection.
Given the weakened immune system during chemotherapy, taking proactive steps to prevent infection is crucial. Here are some practical measures:
It is essential to maintain open communication with your oncologist and healthcare team. You should consult your doctor immediately if:
Disclaimer: This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.

Discover 3 subtle signs of mouth cancer often dismissed as minor issues. Learn why early detection is crucial for effective treatment.
April 23, 2026
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026